2m 2m 2m 2m 2m 2m 2m
Bruker (BRKR)
NASDAQ
$54.61-$1.93 (-3.41%)
Price as of Jun 23, 2026 5:11 PM EDT- $8.6BMarket Cap
- 46.68%1-Year Change
- Medical DevicesIndustry
Bruker (BRKR)
$54.61-$1.93 (-3.41%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.8B N/A | N/A N/A | N/A N/A | 2.5B +4.67% | |
Cost of Revenue | 1.5B -13.42% | 1.7B +18.31% | 1.5B +18.47% | 1.2B +1.38% | |
Gross Profit | 1.6B -4.35% | 1.6B +9.00% | 1.5B +15.90% | 1.3B +7.94% | |
Sales and Marketing Expense | 946.5M +3,304.68% | 27.8M +17.30% | 23.7M -96.10% | 607.4M +8.23% | |
Research and Development Expense | -395.2M +4.97% | -376.5M +27.71% | -294.8M +24.97% | -235.9M +6.84% | |
Depreciation and Amortization Expense | 220.3M +19.86% | 183.8M +59.97% | 114.9M +29.39% | 88.8M -0.34% | |
Total Operating Expenses | 1.5B +8.10% | 1.4B +29.73% | 1.1B +23.30% | 873.0M +9.63% | |
Operating Profit | 68.2M -73.05% | 253.1M -42.07% | 436.9M +0.97% | 432.7M +4.69% | |
Interest Income | 14.8M +59.14% | 9.3M +24.00% | 7.5M +82.93% | 4.1M +355.56% | |
Interest Expense | N/A N/A | -47.9M +192.07% | -16.4M +1.86% | -16.1M +12.59% | |
Interest Income and Expense and Net | 14.8M +138.34% | -38.6M +333.71% | -8.9M -25.83% | -12.0M -10.45% | |
Total Nonoperating Income and Expense | -46.2M 0.00% | -46.2M +25.54% | -36.8M +95.74% | -18.8M -4.57% | |
Income before Taxes | 22.0M -80.67% | 113.8M -73.44% | 428.5M +3.53% | 413.9M +5.16% | |
Income Taxes | 29.3M +145.92% | -63.8M +161.48% | -24.4M -120.96% | 116.4M +3.01% | |
Extraordinary Items | 20.0M -29.82% | 28.5M +28.38% | 22.2M N/A | 0 N/A | |
Net Income | -8.6M -107.56% | 113.8M -73.44% | 428.5M +44.47% | 296.6M +7.04% | |
Net Income from Continuing Operations Applicable to Common | -22.5M -119.77% | 113.8M -73.44% | 428.5M +3.53% | 413.9M +5.16% | |
Basic EPS and Net Income | -0.15 -119.74% | 0.76 -73.97% | 2.92 +46.00% | 2.00 +9.29% | |
Diluted EPS and Net Income | -0.15 -119.74% | 0.76 -73.79% | 2.90 +45.73% | 1.99 +9.94% | |
Basic Weighted Average Shares | 151.8M +101,879,094.63% | 149 N/A | N/A N/A | N/A N/A | |
Diluted Weighted Average Shares | 151.8M N/A | N/A N/A | N/A N/A | N/A N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 298.8M +62.92% | 183.4M -62.44% | 488.3M -24.35% | 645.5M -39.57% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | 0 -100.00% | |
Cash and Cash Equivalents and Short-Term Investments | 298.8M +62.92% | 183.4M -62.44% | 488.3M -24.35% | 645.5M -44.74% | |
Total Current Assets | 2.2B +7.76% | 2.1B -5.13% | 2.2B +2.41% | 2.1B -14.51% | |
Accumulated Depreciation | 692.0M +23.79% | 559.0M +6.64% | 524.2M +17.35% | 446.7M +2.67% | |
Property and Plant and Equipment and Net | 744.8M +11.28% | 669.3M +11.61% | 599.7M +23.14% | 487.0M +19.92% | |
Total Long-Term Assets | 249.3M +7.13% | 232.7M +26.47% | 184.0M +18.63% | 155.1M +119.07% | |
Total Assets | 6.2B +7.49% | 5.8B +36.63% | 4.2B +17.67% | 3.6B -1.05% | |
Income Taxes Payable | 112.5M -5.06% | 118.5M +75.04% | 67.7M +8.67% | 62.3M +35.43% | |
Total Short-Term Debt | 16.6M -48.92% | 32.5M -73.18% | 121.2M +548.13% | 18.7M -83.36% | |
Total Current Liabilities | 1.3B -0.16% | 1.3B +6.59% | 1.2B +31.48% | 914.3M -2.58% | |
Total Long-Term Debt | 1.9B -10.15% | 2.1B +77.70% | 1.2B -3.35% | 1.2B -1.74% | |
Total Long-Term Liabilities | 239.2M -23.09% | 311.0M +90.10% | 163.6M -1.56% | 166.2M +2.47% | |
Total Liabilities | 3.7B -6.52% | 4.0B +40.71% | 2.8B +198.87% | 949.1M -3.18% | |
Retained Earnings | 2.4B -1.87% | 2.4B +3.57% | 2.3B +20.65% | 1.9B +16.06% | |
Total Stockholders Equity | 2.5B +37.91% | 1.8B +29.33% | 1.4B +23.65% | 1.1B +4.04% | |
Total Shares Outstanding | 152.1M +0.31% | 151.7M +4.49% | 145.2M -1.26% | 147.0M -2.47% | |
Cash Flow | |||||
Cash from Operating Activities | 134.1M -46.64% | 251.3M -28.22% | 350.1M +27.59% | 274.4M -2.83% | |
Capital Expenditures | 90.8M -21.25% | 115.3M +7.86% | 106.9M -17.26% | 129.2M +40.43% | |
Cash from Investing Activities | -196.5M -88.82% | -1.8B +439.05% | -326.0M +29.57% | -251.6M +30.77% | |
Dividends Paid | 22.8M -24.50% | 30.2M +2.72% | 29.4M -1.34% | 29.8M +23.14% | |
Cash from Financing Activities | 135.1M -89.01% | 1.2B +735.88% | -193.4M -53.43% | -415.3M -230.31% | |
Financials Ratio | |||||
Gross Margin | 46.27% N/A | N/A N/A | N/A N/A | 51.59% +3.13% | |
Operating Margin | 2.47% N/A | N/A N/A | N/A N/A | 17.10% +0.03% | |
Return on Assets | -0.14% -106.31% | 2.26% -79.24% | 10.90% +33.45% | 8.17% -1.26% | |
Return on Equity | -0.41% -105.63% | 7.21% -79.05% | 34.40% +26.68% | 27.16% -0.44% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | 4.67% -78.46% | |
Current Ratio | 1.73 +7.94% | 1.60 -10.99% | 1.80 -22.11% | 2.31 -12.24% | |
Cash Ratio | 0.23 +63.24% | 0.14 -64.77% | 0.41 -42.46% | 0.71 -37.97% | |
Debt-to-Equity Ratio | 0.76 -35.29% | 1.18 +26.36% | 0.93 -14.99% | 1.09 -12.17% | |
Debt-to-Assets Ratio | 0.30 -16.97% | 0.36 +19.64% | 0.30 -10.69% | 0.34 -7.63% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow